New York City Eye Study (NYCES)
Launched by COLUMBIA UNIVERSITY · Aug 7, 2023
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The New York City Eye Study (NYCES) is a research project aimed at improving eye and vision health for adults aged 21 and older. The study will conduct eye health screenings to check for conditions such as glaucoma, cataracts, diabetic retinopathy, and other vision impairments. This is important as these conditions can lead to serious vision problems, including blindness. While the study is not yet recruiting participants, it will focus on individuals who live independently in affordable housing developments and their neighborhoods.
To be eligible for the study, you need to be at least 21 years old and live in the specified areas. However, if you have a serious illness with a life expectancy of less than a year, or if you have difficulty understanding or providing consent due to conditions like dementia, you won’t be able to participate. If you join the study, you can expect to undergo eye screenings that will help researchers better understand and address vision health in the community. This research is a valuable opportunity to contribute to the understanding of eye health and potentially improve care for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals age 21 and older.
- • Living independently in an affordable housing development and surrounding neighborhoods.
- Exclusion Criteria:
- • Self-reported terminal illness with life expectancy less than 1 year.
- • Inability to provide informed consent due to dementia or other reasons.
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Lisa A. Hark
Principal Investigator
Columbia University Department of Ophthalmology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported